TP53 and diffuse large B-cell lymphoma: To explore the feasibility of predicting TP53 mutation risk by immunohistochemical staining(IHC)pattern of P53 in Chinese diffuse large B-cell lymphoma(DLBCL)and its correlation with a prognostic difference.